Liraglutide In Overweight Patients With Type 1 Diabetes

NCT01753362 · Completed

Last updated 2026-05-28

This clinical trial tested the medication liraglutide in adults who have both type 1 diabetes and overweight or obesity.

Status Completed The study has finished.

Phase Phase 3 Confirms effectiveness in a large group before approval.

Type Interventional (clinical trial)

Design Randomized, double-blind treatment study

Participants 84 people

Who can join Ages 18–75 · all sexes

Timeline Started 2012-12 · est. completion 2018-02

Where 2 sites · United States

What this study is testing ClinicalTrials.gov NCT01753362 ↗

Description as written by the study sponsor.

The purpose of this study is to examine the effects of liraglutide (a drug used to treat type 2 diabetes) on glucose (sugar) control over the 26 week study period when used in addition to insulin.

Treatments tested

liraglutide Drug
placebo Drug

Main thing measured	HbA1c
Sponsor	University at Buffalo
Conditions studied	Type 1 Diabetes
GLP-1 drugs	liraglutide

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT01753362 ↗